Another multinational pharmaceutical giant AstraZeneca successfully settled in Chengdu high tech Zone

[trends of pharmaceutical network industry] in recent years, Chengdu high tech Zone has made efforts in strategic emerging industries, and its biological industry has risen strongly, becoming an important pole in China's biological territory The author learned that during the second China International Import Expo recently held, another multinational pharmaceutical giant settled in Chengdu high tech Zone, namely Chengdu high tech Zone signed a memorandum of strategic cooperation with AstraZeneca, the exhibitor It is reported that AstraZeneca's western headquarters is positioned as a regional headquarters and will become one of the four major headquarters of AstraZeneca in China It will coordinate the overall operation of Western China and build projects including AstraZeneca business innovation center and industrial incubator The business innovation center will focus on the integration of diagnosis and treatment AstraZeneca provides a platform to integrate upstream and downstream enterprises and solutions in the industrial chain, with the functions of exhibition, supporting, research and promotion The head of AstraZeneca said that the establishment of the Western headquarters is one of the important strategic bases for the domestic layout of Sichuan and Chengdu high tech Zone Next, the company will make full use of the national (Chengdu) biomedical R & D and innovation industry base and rich talents and clinical resources, introduce more innovative products, expand the coverage of products and services, penetrate into ordinary families, and enable more patients to enjoy medical resources It is understood that in recent years, Chengdu high tech Zone is rising, and it is speeding up the construction of a modern biological industry system with international competitiveness and regional driving force It is reported that Chengdu hi tech Industrial Development Zone ranks sixth on the list of comprehensive competitiveness of China's bio pharmaceutical Park in 2019 Some experts said that in recent years, Chengdu has been developing rapidly in biomedicine, especially in industry The good human environment and rich biomedical resources in the land of abundance are important aspects to support the development of biomedicine in Chengdu in the future   Sichuan Province, the Ministry of science and technology and the national health and Health Commission have clearly established a pilot demonstration base for the transfer and transformation of major national science and technology special achievements in major new drug creation based on Chengdu Tianfu international biological city It is expected that by 2025, the base will gather 800 enterprises and the output value of biomedical related industries will exceed 50 billion yuan They will support 15 new drug certificates, including 8-10 original new drugs 。 In the future, the demonstration base will become one of the major innovation bases for new drug creation with influence and competitiveness in China, which will effectively promote the transformation of advanced achievements in the field of national new drug research and development in Chengdu, and promote the development of related industries such as biological drugs According to the relevant person in charge of Chengdu hi tech Zone, in recent years, Chengdu hi tech Zone aims to cultivate a new hundred billion industrial cluster, and cooperates with Shuangliu district to build Chengdu Tianfu international biological city around the four major industries of biomedicine, biomedical engineering, biological service and health new economy, so as to accelerate the creation of a biological industry ecosystem of "four chains, one community and one system" At present, the ecology of Chengdu's construction of advanced medical and health industry has been continuously improved, and a relatively complete industrial system has been basically formed, covering the cultivation and cultivation of medicinal materials, pharmaceutical R & D and manufacturing, pharmaceutical commerce, medical services, health services, etc in 2018, the scale of the city's medical and health industry reached more than 300 billion yuan In addition, the data shows that from January to September this year, the output value of the above designated industrial enterprises in the biological industry of Chengdu high tech Zone reached 18.43 billion yuan, and the main business income of the above designated pharmaceutical industry reached 17.67 billion yuan, an increase of 20.5% 742 newly registered health industry enterprises increased by 27.4% year on year 11 new varieties of 100 million yuan were added It is understood that one of the successful projects one belt, one road, along the astral, is to introduce professional projects and provide industrial support for the incubator project With the success of AstraZeneca in Chengdu high tech Zone, the industrial incubator will rely on the advantages of AstraZeneca in the world Meanwhile, city one belt, one road initiative, Chengdu has also made its innovative imports into Chengdu High-tech Zone, and some Future Ltd products will be sold from Chengdu to the whole country.